Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1038/s41598-021-04666-x
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2022
- Urheber
-
Liu, Jingjin
Veldeman, Michael
Höllig, Anke
Nolte, Kay
Liebenstund, Lisa Cathrin
Willuweit, Antje
Langen, Karl-Josef
Rossaint, Rolf
Coburn, Mark
- DOI
-
10.18154/RWTH-CONV-250143
- URN
-
urn:nbn:de:101:1-2023040206493550417355
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Jingjin
- Veldeman, Michael
- Höllig, Anke
- Nolte, Kay
- Liebenstund, Lisa Cathrin
- Willuweit, Antje
- Langen, Karl-Josef
- Rossaint, Rolf
- Coburn, Mark
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2022
Ähnliche Objekte (12)
Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study
Characterization of Transgenic Mouse Models of Alzheimer's Disease and Related Dementia
Präklinische Untersuchungen und therapeutische Bewertung eines neuartigen Peptidliganden im ALS spezifischen SOD1*G93A Mausmodell
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial
Pharmakokinetische Charakterisierung D-enantiomerer Peptide zur Therapie der Alzheimer'schen Demenz
In vivo imaging of brain tumors using the PSMA-selective PET ligands [68Ga]Ga-PSMA-HBED-CC and [18F]DCFPyL in rat glioma models
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study
Characterization of Transgenic Mouse Models of Alzheimer's Disease and Related Dementia
Präklinische Untersuchungen und therapeutische Bewertung eines neuartigen Peptidliganden im ALS spezifischen SOD1*G93A Mausmodell
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial
Pharmakokinetische Charakterisierung D-enantiomerer Peptide zur Therapie der Alzheimer'schen Demenz
In vivo imaging of brain tumors using the PSMA-selective PET ligands [68Ga]Ga-PSMA-HBED-CC and [18F]DCFPyL in rat glioma models
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study
Characterization of Transgenic Mouse Models of Alzheimer's Disease and Related Dementia
Präklinische Untersuchungen und therapeutische Bewertung eines neuartigen Peptidliganden im ALS spezifischen SOD1*G93A Mausmodell
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial
Pharmakokinetische Charakterisierung D-enantiomerer Peptide zur Therapie der Alzheimer'schen Demenz
In vivo imaging of brain tumors using the PSMA-selective PET ligands [68Ga]Ga-PSMA-HBED-CC and [18F]DCFPyL in rat glioma models
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours